Who owns Bushido Capital US Equity ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SMRI from SEC Form 13F filings across 8 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 8 institutions disclosed 13.7M shares of Bushido Capital US Equity ETF worth $562.1M — about 102.7% of shares outstanding; the largest disclosed holder is Sepio Capital, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
8
13F holders
$562.1M
value, 2026 filers
102.7%
of shares outstanding (13.7M sh)
2
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of SMRI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Sepio Capital, LP | 13.6M | $556.0M | 28.0% | 101.6% | -0.1% |
| 2 | JPMORGAN CHASE & CONEW | 79,502 | $3.3M | 0.0% | 0.6% | new |
| 3 | GTS SECURITIES LLCNEW | 26,486 | $1.1M | 0.0% | 0.2% | new |
| 4 | Cambridge Investment Research Advisors, Inc. | 11,803 | $484,000 | 0.0% | 0.1% | +20.7% |
| 5 | Beacon Pointe Advisors, LLC | 10,974 | $450,223 | 0.0% | 0.1% | +14.0% |
| 6 | Black Diamond Financial, LLC | 8,926 | $366,201 | 0.0% | 0.1% | -7.4% |
| 7 | MARATHON CAPITAL MANAGEMENT | 8,640 | $354,467 | 0.1% | 0.1% | +0.1% |
| 8 | BLAIR WILLIAM & CO/IL | 30 | $1,231 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.